The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans.
While less than half of large employers currently cover the new generation of obesity drugs, an additional 18% say they're considering adding them amid surging interest, according to preliminary findings from 1,062 firms surveyed by Mercer, a human-resources consulting firm.
"There are just thousands and thousands of patients reaching out to us," said James Wantuck, associate chief medical officer at health-services company Accolade Inc. Employers have a tough choice, he said, because the medicines "work really well" but "they're very expensive."
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
